M28 Capital Management

Latest statistics and disclosures from M28 Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are WVE, IVVD, RCKT, GUTS, SWTX, and represent 79.50% of M28 Capital Management's stock portfolio.
  • Reduced shares in these 2 stocks: WVE, SLN.
  • M28 Capital Management was a net seller of stock by $-6.3M.
  • M28 Capital Management has $77M in assets under management (AUM), dropping by -43.00%.
  • Central Index Key (CIK): 0001807489

Tip: Access up to 7 years of quarterly data

Positions held by M28 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for M28 Capital Management

M28 Capital Management holds 11 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Wave Life Sciences SHS (WVE) 39.9 $31M -11% 6.2M 4.99
 View chart
Adagio Therapeutics (IVVD) 13.2 $10M 9.2M 1.10
 View chart
Rocket Pharmaceuticals (RCKT) 10.8 $8.3M 386k 21.53
 View chart
Fractyl Health (GUTS) 10.3 $7.9M 1.9M 4.27
 View chart
Springworks Therapeutics (SWTX) 5.4 $4.2M 110k 37.67
 View chart
Silence Therapeutics Ads (SLN) 4.6 $3.5M -38% 185k 19.00
 View chart
Bridgebio Pharma (BBIO) 4.0 $3.1M 121k 25.33
 View chart
Curis (CRIS) 3.8 $2.9M 422k 6.90
 View chart
Tg Therapeutics (TGTX) 3.7 $2.9M 162k 17.79
 View chart
Arrowhead Pharmaceuticals (ARWR) 2.3 $1.8M 67k 25.99
 View chart
Proqr Thrapeutics N V Shs Euro (PRQR) 2.2 $1.7M 1.0M 1.66
 View chart

Past Filings by M28 Capital Management

SEC 13F filings are viewable for M28 Capital Management going back to 2021